Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1364761 | Bioorganic & Medicinal Chemistry Letters | 2008 | 6 Pages |
5-(1,3,4-Oxadiazol-2-yl)pyrimidine derivative 1 was identified as a new class of FLT3 inhibitor from our compound library. With the aim of enhancement of antitumor activity of 2 prepared by minor modification of1, structure optimization of side chains at the 2-, 4-, and 5-positions of the pyrimidine ring of 2 was performed to improve the metabolic stability. Introduction of polar substituents on the 1,3,4-oxadiazolyl group contributed to a significant increase in the metabolic stability. As a result, a series of compounds showed increased efficacy against MOLM-13 xenograft model in mice by oral administration.
Graphical abstractThe synthesis and structure–activity relationship studies of a novel series of FLT3 inhibitors are described. Compound 23r possesses best efficacy against tumor xenograft model by oral administration.Figure optionsDownload full-size imageDownload as PowerPoint slide